 Women who have a high risk of developing breast or ovarian cancer due to a known germline mutation in the BRCA12, PTEN, CDH1, or TP53 cancer susceptibility genes, or due to strong family history of either breast or ovarian cancer, in the absence of known cancer susceptibility gene mutation. 